PI-RADS v2.1 and PSAD for the prediction of clinically significant prostate cancer among patients with PSA levels of 4–10 ng/ml
Crossref DOI link: https://doi.org/10.1038/s41598-024-57337-y
Published Online: 2024-03-19
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wen, Jing
Liu, Wei
Shen, Xiaocui
Hu, Wei
Text and Data Mining valid from 2024-03-19
Version of Record valid from 2024-03-19
Article History
Received: 10 December 2023
Accepted: 18 March 2024
First Online: 19 March 2024
Competing interests
: The authors declare no competing interests.